馬ヘルスケア市場規模、シェア、動向分析レポート：製品別、適応症別、活動別、流通チャネル別、地域別、セグメント別予測、2024年～2030年

馬ヘルスケア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の馬ヘルスケア市場規模は2030年までに59億1,000万米ドルに達し、予測期間中のCAGRは8.32％を記録すると予測されています。

製品の研究開発の増加、馬用診断薬の需要、主要な業界関係者による投資、馬の疾病の有病率の上昇は、市場成長の主な要因の一部です。例えば、2021年9月、米国農務省は動物栄養・健康分野に約30億米ドルを投資しました。

COVID-19の大流行は、特に競馬／スポーツ部門に顕著な影響を与えました。馬のケアサービスへのアクセスが減少し、馬術ショーが中止されました。COVID-19の結果、教育、トレーニング、競合、イベント、観光関連活動、レクリエーション活動のすべてが中止されました。競馬は、乗馬の需要とともに世界中で悪影響を受けた。EU内で競馬を続けていたのはスウェーデンだけだった。フランスの馬産業クラスターであるHippoliaが実施した調査によると、回答者の68.8％が不足分の回復は不可能だと考えており、すべての馬術競技が廃止されました。スポーツ馬の損失は、推計で合計3億8,589万米ドルに上った。しかし、閉鎖措置の緩和や馬ヘルスケアへのアクセスの改善により、2021年には市場は回復しました。

技術的進歩、研究開発、市場参入企業による馬の診断におけるイニシアチブの高まりは、市場を牽引する重要な要因です。例えば、米国獣医師会（American Veterinary Medical Association）が2022年7月に発表した論文によると、臨床的な頭頸部合併症を有する馬の画像診断に利用される独自のヘリカルファンビームベースCTの診断性能を評価する研究が実施されました。合計120頭以上の馬が対象となり、2つの大学病院で頭頸部CTスキャンを受けた馬のカルテが調査されました。年齢、性別、犬種、主訴、鎮静剤の使用量、手術時間、さらなる画像診断技術の使用、画像診断、臨床診断、および画像診断に関連する問題がすべて記録されました。CTシステムはスキャン時間が短く、馬の歯と副鼻腔の定期的な撮影に信頼できる有用性があることが証明されました。

さらに、馬の疾病の流行が増加していることも市場成長を促進する要因の一つです。例えば、ウエストナイルウイルスは、2022年9月にカリフォルニア州食品農業局によって、一過性の発熱と神経症状を示していたネバダ郡の10歳のワクチン未接種のクォーターホース種馬で陽性と確認されました。これは2022年にカリフォルニア州で確認された8例目のウマWNV症例でした。その他、カーン州3例、ネバダ州1例、サクラメント州1例、サンルイスオビスポ州1例、テハマ州1例、チュレア州3例の計6郡で陽性例が確認されました。これにより、馬の病気に関する認識が広まると同時に、馬への適時ワクチン接種の需要が高まることが期待されます。

馬ヘルスケア市場レポートハイライト

• 製品別では、医薬品が2023年に25.96%以上のシェアを占め、市場を独占しました。
• 再生医療と幹細胞治療ソリューションからなるその他製品セグメントは、予測期間中に最も急成長するセグメントと予測されます。
• 適応症別では、寄生虫感染症分野が2023年に26.56%超の最大シェアを占めました。これは、内部寄生虫および外部寄生虫を駆除するための効果的な寄生虫駆除薬に対する需要の高まりによるものです。
• スポーツ／レース活動分野は、2023年に56.38%超の収益シェアで市場を独占し、予測期間中に最も速い速度で成長すると予測されます。
• 流通チャネル別では、動物病院と診療所が2023年に最大のシェアを占めました。eコマース分野は予測期間中に最も速いCAGRで拡大すると予測されています。
• 北米と欧州は2023年に注目すべきシェアを占めました。アジア太平洋は、馬術レース/スポーツ分野の芽生えにより、予測期間に有利な成長を示すと予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 馬ヘルスケア市場の変動動向と範囲

• 市場系統の見通し
• 市場力学
• 馬ヘルスケア市場分析ツール

第4章 馬ヘルスケア市場： 製品推定・動向分析

• セグメントダッシュボード
• 馬用ヘルスケア市場製品変動分析
• 馬ヘルスケア市場の規模と動向分析、製品別、2018年～2030年

第5章 馬ヘルスケア市場： 適応症の推定・動向分析

• セグメントダッシュボード
• 馬ヘルスケア市場の変動分析
• 馬ヘルスケア市場の規模と動向分析、適応症、2018年～2030年

第6章 馬ヘルスケア市場：活動推定・動向分析

• セグメントダッシュボード
• 馬ヘルスケア市場の変動分析
• 馬ヘルスケア市場の規模と動向分析、活動タイプ、2018年～2030年

第7章 馬ヘルスケア市場：流通チャネル別の推定・動向分析

• セグメントダッシュボード
• 馬ヘルスケア市場の変動分析
• 馬ヘルスケア市場規模と動向分析、流通チャネル別、2018年～2030年

第8章 馬ヘルスケア市場：国推定・動向分析、製品、適応症、活動、流通チャネル別

• 地域ダッシュボード
• 馬ヘルスケア市場シェア、地域別、2023年および2030年
• 地域展望
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 市場参入企業の分類
• Participants Overview
• 財務実績
• 製品ベンチマーク
• 市況分析、2023年（ヒートマップ分析）
• 戦略マッピング
  • 合併と買収
  • 打ち上げ
  • パートナーシップとコラボレーション
  • 拡大
  • その他
• 企業プロファイル
  • Zoetis
  • Arthrex Inc.
  • Dechra Pharmaceuticals
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska Corporation
  • Merck &Co Inc.
  • Esaote SpA
  • IDEXX Laboratories Inc.
  • Covetrus Inc.
  • Elanco
  • Cargill
• その他の主要市場プレーヤーのリスト

第10章 重要なポイント

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 4 Global Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 5 Global Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 6 Global Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 7 Global Equine Healthcare Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 10 North America Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 11 North America Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 12 North America Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 13 U.S. Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 15 U.S. Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 16 U.S. Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 17 Canada Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 18 Canada Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 19 Canada Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 20 Canada Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 21 Mexico Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 22 Mexico Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 23 Mexico Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 24 Mexico Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 25 Europe Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 27 Europe Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 28 Europe Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 29 Europe Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 30 Germany Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 31 Germany Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 32 Germany Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 33 Germany Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 34 UK Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 35 UK Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 36 UK Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 37 UK Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 38 France Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 39 France Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 40 France Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 41 France Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 42 Italy Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 43 Italy Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 44 Italy Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 45 Italy Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 46 Spain Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 47 Spain Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 48 Spain Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 49 Spain Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 50 Denmark Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 51 Denmark Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 52 Denmark Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 53 Denmark Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 54 Sweden Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 55 Sweden Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 56 Sweden Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 57 Sweden Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 58 Norway Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 59 Norway Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 60 Norway Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 61 Norway Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 62 Russia Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Russia Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 64 Russia Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 65 Russia Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 66 Netherlands Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 67 Netherlands Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 68 Netherlands Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 69 Netherlands Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 70 Switzerland Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 71 Switzerland Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 72 Switzerland Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 73 Switzerland Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 79 China Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 80 China Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 81 China Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 82 China Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 83 Japan Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 84 Japan Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 85 Japan Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 86 Japan Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 87 India Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 88 India Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 89 India Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 90 India Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 91 South Korea Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 92 South Korea Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 93 South Korea Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 94 South Korea Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 95 Australia Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 96 Australia Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 97 Australia Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 98 Australia Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 99 Thailand Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 100 Thailand Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 101 Thailand Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 102 Thailand Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 103 Latin America Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
• Table 104 Latin America Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 105 Latin America Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 106 Latin America Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 107 Latin America Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 108 Brazil Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 109 Brazil Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 110 Brazil Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 111 Brazil Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 112 Argentina Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 113 Argentina Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 114 Argentina Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 115 Argentina Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 116 Middle East & Africa Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
• Table 117 Middle East & Africa Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 118 Middle East & Africa Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 119 Middle East & Africa Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 120 Middle East & Africa Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 121 South Africa Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 122 South Africa Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 123 South Africa Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 124 South Africa Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 125 Saudi Arabia Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 126 Saudi Arabia Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 127 Saudi Arabia Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 128 Saudi Arabia Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 129 UAE Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 130 UAE Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 131 UAE Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 132 UAE Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 133 Kuwait Equine Healthcare Market, By Product, 2018 - 2030 (USD Million)
• Table 134 Kuwait Equine Healthcare Market, By Indication, 2018 - 2030 (USD Million)
• Table 135 Kuwait Equine Healthcare Market, By Activity, 2018 - 2030 (USD Million)
• Table 136 Kuwait Equine Healthcare Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Equine Healthcare Market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Equine Healthcare Market, for Product, 2018 - 2030 (USD Million)
• Fig. 15 Global Equine Healthcare Market, for Pharmaceuticals, 2018 - 2030 (USD Million)
• Fig. 16 Global Equine Healthcare Market, for Diagnostics, 2018 - 2030 (USD Million)
• Fig. 17 Global Equine Healthcare Market, for Software & Services, 2018 - 2030 (USD Million)
• Fig. 18 Global Equine Healthcare Market, for Indication, 2018 - 2030 (USD Million)
• Fig. 19 Global Equine Healthcare Market, for Musculoskeletal Disorders, 2018 - 2030 (USD Million)
• Fig. 20 Global Equine Healthcare Market, for Parasitic Infections, 2018 - 2030 (USD Million)
• Fig. 21 Global Equine Healthcare Market, for Equine Herpes Virus, 2018 - 2030 (USD Million)
• Fig. 22 Global Equine Healthcare Market, for Equine Viral Arteritis (EVA), 2018 - 2030 (USD Million)
• Fig. 23 Global Equine Healthcare Market, for Equine Influenza, 2018 - 2030 (USD Million)
• Fig. 24 Global Equine Healthcare Market, for West Nile Virus, 2018 - 2030 (USD Million)
• Fig. 25 Global Equine Healthcare Market, for Tetanus, 2018 - 2030 (USD Million)
• Fig. 26 Global Equine Healthcare Market, for Other Indications, 2018 - 2030 (USD Million)
• Fig. 27 Global Equine Healthcare Market, for Activity, 2018 - 2030 (USD Million)
• Fig. 28 Global Equine Healthcare Market, for Sports/Racing, 2018 - 2030 (USD Million)
• Fig. 29 Global Equine Healthcare Market, for Recreation, 2018 - 2030 (USD Million)
• Fig. 30 Global Equine Healthcare Market, for Other Activities, 2018 - 2030 (USD Million)
• Fig. 31 Global Equine Healthcare Market, for Distribution Channel, 2018 - 2030 (USD Million)
• Fig. 32 Global Equine Healthcare Market, for Veterinary Hospitals & Clinics, 2018 - 2030 (USD Million)
• Fig. 33 Global Equine Healthcare Market, for E-commerce, 2018 - 2030 (USD Million)
• Fig. 34 Global Equine Healthcare Market, for Equestrian Facilities 2018 - 2030 (USD Million)
• Fig. 35 Global Equine Healthcare Market, for Other Channels 2018 - 2030 (USD Million)
• Fig. 36 Regional Outlook, 2023 & 2030
• Fig. 37 North America Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 38 U.S. Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 39 Canada Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 40 Europe Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 41 Germany Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 42 UK Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 43 France Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 44 Italy Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 45 Spain Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 46 Denmark Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 47 Sweden Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 48 Norway Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 49 Russia Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 50 Netherlands Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 51 Switzerland Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 52 Asia Pacific Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 53 Japan Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 54 China Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 55 India Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 56 Australia Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 57 South Korea Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 58 Thailand Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 59 Latin America Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 60 Brazil Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 61 Mexico Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 62 Argentina Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 63 Middle East and Africa Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 64 South Africa Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 65 Saudi Arabia Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 66 UAE Equine Healthcare Market, 2018 - 2030 (USD Million)
• Fig. 67 Kuwait Equine Healthcare Market, 2018 - 2030 (USD Million)

Equine Healthcare Market Growth & Trends:

The global equine healthcare market size is expected to reach USD 5.91 billion by 2030, registering a CAGR of 8.32% during the forecast period, according to a new report by Grand View Research, Inc. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

Equine Healthcare Market Report Highlights:

• Based on product, the pharmaceuticals segment dominated the market with a share of over 25.96% in 2023 owing to a high uptake and wide availability of these products
• The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period
• Based on indication, parasite infections segment held the largest share of over 26.56% in 2023. It is due to the growing demand for effective parasiticides for the control of internal and external parasites
• The sports/racing activity segment dominated the market with a revenue share of over 56.38% in 2023 and is anticipated to grow at the fastest rate during the forecast period
• Based on distribution channel, veterinary hospitals and clinics held the largest share in 2023. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period
• North America and Europe held notable shares in 2023. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Equine Healthcare Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Include Growing R&D Initiatives,
    • 3.2.1.2. Rise In Equine Health Complications,
    • 3.2.1.3. Rising Popularity Of Equine-Assisted Therapy
    • 3.2.1.4. Emergence Of Artificial Intelligence (AI) In Equine Health
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Expenditure
    • 3.2.2.2. Availability of Substitutes
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Equine Healthcare Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Horse Population, by Key Countries, 2018 - 2023
  • 3.3.5. Pricing Analysis
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Equine Healthcare Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Equine Healthcare Market Product Movement Analysis
• 4.3. Equine Healthcare Market Size & Trend Analysis, By Product, 2018-2030 (USD Million)
  • 4.3.1. Vaccines
    • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.2. Pharmaceuticals
    • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.2. Parasiticides
    • 4.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.3. Anti-infectives
    • 4.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.4. Anti-inflammatory & Analgesics
    • 4.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2.5. Other Pharmaceuticals
    • 4.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.3. Medicinal Feed Additives
    • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.4. Orthobiologics
    • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.5. Diagnostics
    • 4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.5.2. Diagnostic Test Kits
    • 4.3.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.5.3. Diagnostic Equipment
    • 4.3.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.6. Software & Services
    • 4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.2. Practice Management Software
    • 4.3.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.3. Imaging Software
    • 4.3.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.4. Telehealth Software
    • 4.3.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.6.5. Other Software
    • 4.3.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.7. Other Products
    • 4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Equine Healthcare Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Equine Healthcare Market Movement Analysis
• 5.3. Equine Healthcare Market Size & Trend Analysis, Indication, 2018-2030 (USD Million)
  • 5.3.1. Musculoskeletal Disorders
    • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Parasitic Infections
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Equine Herpes Virus
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Equine Viral Arteritis (EVA)
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. Equine Influenza
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.6. West Nile Virus
    • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.7. Tetanus
    • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.8. Other Indications
    • 5.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Equine Healthcare Market: By Activity Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Equine Healthcare Market Movement Analysis
• 6.3. Equine Healthcare Market Size & Trend Analysis, Activity type, 2018-2030 (USD Million)
  • 6.3.1. Sports/Racing
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Recreation
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Other Activities
    • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Equine Healthcare Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Equine Healthcare Market Movement Analysis
• 7.3. Equine Healthcare Market Size & Trend Analysis, By Distribution Channel, 2018-2030 (USD Million)
  • 7.3.1. Veterinary Hospitals & Clinics
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. E-commerce
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Equestrian Facilities
    • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Other Channels
    • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Equine Healthcare Market: Country Estimates & Trend Analysis, by Product, Indication, Activity & Distribution Channel

• 8.1. Regional Dashboard
• 8.2. Equine Healthcare Market Share, By Region, 2023 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competition Insights
    • 8.4.2.3. U.S. Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competition Insights
    • 8.4.3.3. Canada Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competition Insights
    • 8.4.4.3. Mexico Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competition Insights
    • 8.5.2.3. UK Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competition Insights
    • 8.5.3.3. Germany Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competition Insights
    • 8.5.4.3. France Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competition Insights
    • 8.5.5.3. Italy Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competition Insights
    • 8.5.6.3. Spain Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competition Insights
    • 8.5.7.3. Denmark Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competition Insights
    • 8.5.8.3. Sweden Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competition Insights
    • 8.5.9.3. Norway Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Netherlands
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competition Insights
    • 8.5.10.3. Netherlands Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Russia
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competition Insights
    • 8.5.11.3. Russia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.12. Switzerland
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competition Insights
    • 8.5.12.3. Switzerland Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competition Insights
    • 8.6.2.3. Japan Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competition Insights
    • 8.6.3.3. China Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competition Insights
    • 8.6.4.3. India Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competition Insights
    • 8.6.5.3. Australia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competition Insights
    • 8.6.6.3. South Korea Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competition Insights
    • 8.6.7.3. Thailand Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competition Insights
    • 8.7.2.3. Brazil Equine Healthcare Market Estimates And Forecasts, 2018 - 2030
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competition Insights
    • 8.7.3.3. Argentina Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competition Insights
    • 8.8.2.3. South Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competition Insights
    • 8.8.3.3. Saudi Arabia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competition Insights
    • 8.8.4.3. UAE Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competition Insights
    • 8.8.5.3. Kuwait Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Participants Overview
• 9.3. Financial Performance
• 9.4. Product Benchmarking
• 9.5. Market Position Analysis, 2023 (Heat Map Analysis)
• 9.6. Strategy Mapping
  • 9.6.1. Mergers And Acquisitions
  • 9.6.2. Launch
  • 9.6.3. Partnerships & Collaborations
  • 9.6.4. Expansion
  • 9.6.5. Others
• 9.7. Company Profiles
  • 9.7.1. Zoetis
    • 9.7.1.1. Participant's overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. Product benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. Arthrex Inc.
    • 9.7.2.1. Participant's overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. Product benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. Dechra Pharmaceuticals
    • 9.7.3.1. Participant's overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. Product benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Boehringer Ingelheim
    • 9.7.4.1. Participant's overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. Product benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Ceva Sante Animale
    • 9.7.5.1. Participant's overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. Product benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. Heska Corporation
    • 9.7.6.1. Participant's overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. Product benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. Merck & Co Inc.
    • 9.7.7.1. Participant's overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. Product benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. Esaote SpA
    • 9.7.8.1. Participant's overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. Product benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. IDEXX Laboratories Inc.
    • 9.7.9.1. Participant's overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. Product benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. Covetrus Inc.
    • 9.7.10.1. Participant's overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. Product benchmarking
    • 9.7.10.4. Strategic initiatives
  • 9.7.11. Elanco
    • 9.7.11.1. Participant's overview
    • 9.7.11.2. Financial performance
    • 9.7.11.3. Product benchmarking
    • 9.7.11.4. Strategic initiatives
  • 9.7.12. Cargill
    • 9.7.12.1. Participant's overview
    • 9.7.12.2. Financial performance
    • 9.7.12.3. Product benchmarking
    • 9.7.12.4. Strategic initiatives
• 9.8. List of Other Key Market Players

Chapter 10. Key Takeaways